MIAMI, Aug. 17, 2004 (PRIMEZONE) -- Stockwire.com Releases its Movers and Shakers List: Power3 Medical Products Inc. (OTCBB:PWRM), Amgen (Nasdaq:AMGN), Home Depot (NYSE:HD), Intel Corp. (Nasdaq:INTC)
Power3 Medical Products Inc. is a biotechnology company that uses its proprietary technology to discover protein footprints, pathways and mechanisms of diseases in patients. These discoveries are being used to develop screening and diagnostic tests for the early detection and treatment of disease. The Company has over 190 validated biomarkers. It operates a proteomics laboratory in The Woodlands, Texas.
To view the full report, go to www.stockwire.com
Stockwire.com is an online financial destination where investors can go to research new investment ideas. We are focused on finding emerging growth companies that do not necessarily have widespread analyst coverage on Wall Street. The site also provides investors with full coverage of quotes, charts, and news for all publicly listed stocks in the U.S.
If you'd like a complete list of all of our profiled companies, visit: www.stockwire.com
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.stockwire.com. Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. Reproduction without written permission is prohibited. Stockwire Research Group, Inc. has been compensated 10,000 cash for the release of this press wire by a third party shareholder or for the creation and distribution of the PWRM research report.